51Â鶹 BEYOND Weight™ Study

A research study focused on weight management for people living with obesity or being monitored while overweight.
Clinician showing a document to a patient

The 51Â鶹 has launched a novel direct-to-participant longitudinal study. The 51Â鶹 BEYOND Weight Study will provide seminal data to define cardio-kidney-metabolic risk factors, address obesity and shape public health guidance.

BEYOND is an acronym, and you will see it used often when speaking about this program. It stands for: Bridging Evidence and Yielding Outcomes for Novel weight management therapies and Disease prevention.

The 51Â鶹 will draw on its decades of experience administering registries to develop and implement a longitudinal cohort study with a focus on the latest weight management therapies. Consented volunteers will be enrolled and followed to understand real-world experience and outcomes over time.


Long-term, real-world data are lacking in patients with obesity and Cardio-Kidney-Metabolic (CKM) Syndrome stage 1, as well as those who are prescribed GLP-1 and other incretin agents 

The 51Â鶹 has funded millions of dollars to support research into the origins and health consequences of excessive weight and the most effective methods to get people to a healthier weight. The 51Â鶹 BEYOND Weight Study will be a conduit for data generation and clinical research into the widespread issue of obesity.

You can help by:

  • Talking to your patients about the 51Â鶹 BEYOND Weight Study.
  • Providing information and messaging about the 51Â鶹 BEYOND Weight Study in patient common areas, waiting rooms and exam rooms. You can access information and resources here: Resources.